SBRA FY 2024 Earnings Report — Sabra Health Care REIT, Inc. Revenue & Financial Results | Market Cap Arena

Sabra Health Care REIT, Inc.SBRA

FY 2024 Earnings

Reported February 19, 2025

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2024	Prior Q	FY 2023	QoQ Change	YoY Change
Revenue	$703M	—	$648M	—	8.6%
Op. Income	$257M	—	$222M	—	15.9%
Gross Margin	67.7%	—	69.8%	—	-2.1pp
Net Margin	18.0%	—	2.1%	—	15.9pp
EPS (Diluted)	$0.54	—	$0.06	—	813.7%
Free Cash Flow	$311M	—	$301M	—	3.3%

Revenue Flow

Item	Amount
REVENUE	$703M
Cost of Revenue	$227M
GROSS PROFIT	$476M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$50M
SG&A Expenses	$50M
Other Expenses	$169M
Operating Expenses	$219M
Cost & Expenses	$446M
OPERATING INCOME	$257M
Interest Income	$0
Interest Expense	$115M
Other Income/Expenses	-$129M
INCOME BEFORE TAX	$128M
Income Tax Expense	$1M
Net Income from Continuing Ops	$127M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$127M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$127M
D&A	$170M
EBIT	$243M
EBITDA	$413M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$703M
Cost of Revenue	$227M
GROSS PROFIT	$476M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$50M
SG&A Expenses	$50M
Other Expenses	$169M
Operating Expenses	$219M
Cost & Expenses	$446M
OPERATING INCOME	$257M
Interest Income	$0
Interest Expense	$115M
Other Income/Expenses	-$129M
INCOME BEFORE TAX	$128M
Income Tax Expense	$1M
Net Income from Continuing Ops	$127M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$127M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$127M
D&A	$170M
EBIT	$243M
EBITDA	$413M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$127M
Depreciation & Amortization	$170M
Stock-Based Compensation	$9M
Deferred Income Tax	$0
Other Non-Cash Items	$28M
Change in Working Capital	-$23M
OPERATING CASH FLOW	$311M
Capital Expenditure	$0
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$109M
NET CASH FROM INVESTING	-$109M
Net Debt Issuance	$13M
Common Stock Repurchased	$0
Common Dividends Paid	-$280M
Other Financing Activities	-$94.0K
NET CASH FROM FINANCING	-$182M
FREE CASH FLOW	$311M
Net Change in Cash	$20M

Balance Sheet

Item	Amount
Cash & Equivalents	$60M
Short-Term Investments	$0
Net Receivables	$132M
Inventory	$0
Other Current Assets	$6M
TOTAL CURRENT ASSETS	$198M
PP&E (Net)	$0
Goodwill	$0
Intangible Assets	$27M
Long-Term Investments	$183M
Tax Assets	$0
Other Non-Current Assets	$4.9B
TOTAL NON-CURRENT ASSETS	$5.1B
TOTAL ASSETS	$5.3B
Account Payables	$0
Short-Term Debt	$107M
Deferred Revenue	$0
Other Current Liabilities	$118M
TOTAL CURRENT LIABILITIES	$224M
Long-Term Debt	$2.3B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$0
TOTAL NON-CURRENT LIABILITIES	$2.3B
TOTAL LIABILITIES	$2.6B
Common Stock	$2M
Additional Paid-In Capital	$4.6B
Retained Earnings	-$1.9B
Treasury Stock	$0
Accum. Other Comp. Income	$21M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$2.7B
Minority Interest	$0
TOTAL EQUITY	$2.7B
TOTAL LIABILITIES & EQUITY	$5.3B
Total Debt	$2.4B
Net Debt	$2.4B